Basel Medical (BMGL) Depreciation & Amortization (CF) (2023 - 2024)
Basel Medical recorded quarterly Depreciation & Amortization (CF) of $15412.2 in Q4 2024, up 31.68% quarter-over-quarter from $11704.4 in Q4 2023, and up 31.68% year-over-year from $11704.4 in Q1 2024.
Basel Medical's Depreciation & Amortization (CF) history runs 2 years deep, the most recent figure standing at $15412.2 for Q4 2024.
- In Q4 2024, Depreciation & Amortization (CF) rose 31.68% year-over-year to $15412.2; the TTM figure through Jun 2025 stood at $27116.6 (changed N/A YoY), while the FY2025 annual figure was $907397.1, up 132.19% from the prior year.
- Depreciation & Amortization (CF) came in at $15412.2 for Q4 2024 at Basel Medical, up from $11704.4 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $15412.2 in Q4 2024 to a low of $11704.4 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | 930.00 Mn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | 229.00 Mn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | 177.83 Mn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 87.30 Mn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 28.80 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 434.19 Mn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | 16.87 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | - |
| 10 | Basel Medical | 8.57 Mn | 6.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 15,412.17 |
| Dec 31, 2024 | 15,412.17 |
| Dec 31, 2023 | 11,704.42 |
| Dec 31, 2023 | 11,704.42 |